S.501 - Fair Prescription Drug Competition Act

A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs. view all titles (2)

All Bill Titles

  • Official: A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs. as introduced.
  • Short: Fair Prescription Drug Competition Act as introduced.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

Bill’s Views

  • Today: 1
  • Past Seven Days: 5
  • All-Time: 2,603
 
Introduced
 
Senate
Passes
 
House
Passes
 
President
Signs
 

 
02/26/09
 
 
 
 
 
 
 

Official Summary

Fair Prescription Drug Competition Act - Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from commencing to manufacture, market, sell, or distribute a generic version of such drug from the time of the receipt of notice from the generi

Official Summary

Fair Prescription Drug Competition Act - Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from commencing to manufacture, market, sell, or distribute a generic version of such drug from the time of the receipt of notice from the generic manufacturer that an abbreviated new drug application has been submitted for approval until the expiration or forfeiture of the exclusivity period granted to the generic manufacturer.

...Read the Rest




Vote on This Bill

14% Users Support Bill

1 in favor / 6 opposed
 

Send Your Senator a Letter

about this bill Support Oppose Tracking
Track with MyOC